All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
The vector of anti-CEA chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target Human CEA. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-CEA antibody linked to CD28 and CD3ζ signaling domains. And the vector product was designed for the treatment of Colorectal cancer.
CAR Construction : Fig.1 Inhibition of Abl (8019) binding to Ab2 (3H1) on the plate by patients' Ab3 sera by radioimmunoassay. Purified 3H1 was used to coat the plate (500 ng/well) . Foon, K. A., Chakraborty, M., John, W. J., Sherratt, A., Köhler, H., & Bhattacharya-Chatterjee, M. (1995). Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine. The Journal of clinical investigation, 96(1), 334-342. |
CAR Construction : Fig.2 Flow microfluorimetry analysis of the CEA positive colon cancer cell line, LS174-T, with patients' Ab3 sera. Tumor cells were reacted with Ab3 sera (1/100 dilution) from patients immunized with murine Abl 8019. Foon, K. A., Chakraborty, M., John, W. J., Sherratt, A., Köhler, H., & Bhattacharya-Chatterjee, M. (1995). Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccine. The Journal of clinical investigation, 96(1), 334-342. |
CAR Construction : Fig.3 ELISA analysis of the inhibition of biotinytated anti C3d-3H1 antibodies to Fab of 3H1 by Mab 8019 Fab 3H1 coated plates and mouse anti-3H1-16mer serum were incubated in the presence of 8019 or OKT3. Lou, D., & Kohler, H. (1998). Enhanced molecular mimicry of CEA using photoaffinity crosslinked C3d peptide. Nature biotechnology, 16(5), 458-462. |
CAR Construction : Fig.4 Immunofluorescence analysis of CEA-positive MC-38-CEA cells. mAb 8019 was used as a positive control. Baral, R., Saha, A., Chatterjee, S. K., Foon, K. A., Krieg, A. M., Weiner, G. J., & Bhattacharya-Chatterjee, M. (2003). Immunostimulatory CpG oligonucleotides enhance the immune response of anti-idiotype vaccine that mimics carcinoembryonic antigen. Cancer Immunology, Immunotherapy, 52(5), 317. |
CAR Construction : Fig.5 Ab1 (mAb 8019) binding inhibition to Ab2 (3H1) by immune sera. Induction of anti-anti-idiotype antibody (Ab3) in mice after multiple immunizations with 3H1-CpG or 11D10-CpG. Baral, R., Saha, A., Chatterjee, S. K., Foon, K. A., Krieg, A. M., Weiner, G. J., & Bhattacharya-Chatterjee, M. (2003). Immunostimulatory CpG oligonucleotides enhance the immune response of anti-idiotype vaccine that mimics carcinoembryonic antigen. Cancer Immunology, Immunotherapy, 52(5), 317. |
More Published Data More Published Data
There are currently no customer reviews or questions for Anti-CEA (8019) h(CD28-CD3ζ) CAR, pCDCAR1 (CAR-ZP4939). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION